Order Article Reprints

Swadling L, Halliday J, Kelly C, Brown A, Capone S, Ansari MA, Bonsall D, Richardson R, Hartnell F, Collier J, et al. Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines. 2016; 4(3):27. https://doi.org/10.3390/vaccines4030027

Swadling, Leo, John Halliday, Christabel Kelly, Anthony Brown, Stefania Capone, M. Azim Ansari, David Bonsall, Rachel Richardson, Felicity Hartnell, Jane Collier, and et al. 2016. "Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection" Vaccines 4, no. 3: 27. https://doi.org/10.3390/vaccines4030027

Swadling, L., Halliday, J., Kelly, C., Brown, A., Capone, S., Ansari, M. A., Bonsall, D., Richardson, R., Hartnell, F., Collier, J., Ammendola, V., Del Sorbo, M., Von Delft, A., Traboni, C., Hill, A. V. S., Colloca, S., Nicosia, A., Cortese, R., Klenerman, P., ... Barnes, E. (2016). Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection. Vaccines, 4(3), 27. https://doi.org/10.3390/vaccines4030027